Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach

Authors

George P. Christophi, Washington University School of Medicine in St. Louis
Arvind Rengarajan, Washington University School of Medicine in St. Louis
Matthew A. Ciorba, Washington University School of Medicine in St. Louis

Journal

Clinical and Experimental Gastroenterology

Publication Date

2016

Volume

2016

Issue

9

Inclusive Pages

125-130

Document Type

Open Access Publication

DOI

10.2147/CEG.S80237

Rights and Permissions

George P Christophi, Arvind Rengarajan, Matthew A Ciorba. Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach. Clinical and Experimental Gastroenterology. Published 19 May 2016 Volume 2016:9 Pages 125—130. DOI https://dx.doi.org/10.2147/CEG.S80237

Recommended Citation

Christophi, George P.; Rengarajan, Arvind; and Ciorba, Matthew A., "Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach." Clinical and Experimental Gastroenterology. 2016, 9. 125-130. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/5078